- Home
- GANX vs AGMH Comparison
GANX vs AGMH Comparison
Compare GANX & AGMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- AGMH
- Stock Information
- Founded
- GANX 2017
- AGMH 2015
- Country
- GANX United States
- AGMH Hong Kong
- Employees
- GANX N/A
- AGMH N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- AGMH EDP Services
- Sector
- GANX Health Care
- AGMH Technology
- Exchange
- GANX Nasdaq
- AGMH Nasdaq
- Market Cap
- GANX 41.9M
- AGMH 42.4M
- IPO Year
- GANX 2021
- AGMH 2018
- Fundamental
- Price
- GANX $1.85
- AGMH $1.81
- Analyst Decision
- GANX Strong Buy
- AGMH
- Analyst Count
- GANX 4
- AGMH 0
- Target Price
- GANX $7.75
- AGMH N/A
- AVG Volume (30 Days)
- GANX 281.8K
- AGMH 56.6K
- Earning Date
- GANX 11-14-2024
- AGMH 12-27-2024
- Dividend Yield
- GANX N/A
- AGMH N/A
- EPS Growth
- GANX N/A
- AGMH N/A
- EPS
- GANX N/A
- AGMH N/A
- Revenue
- GANX N/A
- AGMH $92,907,172.00
- Revenue This Year
- GANX N/A
- AGMH N/A
- Revenue Next Year
- GANX $300.03
- AGMH N/A
- P/E Ratio
- GANX N/A
- AGMH N/A
- Revenue Growth
- GANX N/A
- AGMH N/A
- 52 Week Low
- GANX $0.89
- AGMH $0.47
- 52 Week High
- GANX $5.33
- AGMH $2.20
- Technical
- Relative Strength Index (RSI)
- GANX 39.86
- AGMH 52.90
- Support Level
- GANX $1.64
- AGMH $1.68
- Resistance Level
- GANX $2.34
- AGMH $1.88
- Average True Range (ATR)
- GANX 0.27
- AGMH 0.13
- MACD
- GANX -0.09
- AGMH -0.01
- Stochastic Oscillator
- GANX 19.90
- AGMH 40.45
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.
About AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an investment holding company. The company focuses on blockchain-oriented ASIC chip design; high-end crypto miner production and fintech technology software service. It generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.